The PennZone

  • Home
  • Non-profit
  • Education
  • Technology
  • Business
  • Construction
  • Marketing
  • Health
  • Entertainment

Nattokinase Supplement for Cardiovascular and Circulatory Support
The PennZone/10270754

Trending...
  • Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers
  • Detained at 95: South Korea's Prosecution of a Religious Leader Draws International Alarm
  • UK Financial Ltd. Opens Test-Phase Maya 3 Liquidity Pool on Uniswap with DEX Screener Visibility for Market-Smoothing Ahead of CATEX Exchange Launch
Nattokinase Heart Health Supplement
AgeImmune's Nattokinase is one of the purest professional grade supplement on the market which is beneficial for overall heart health.

NEW YORK - PennZone -- Dr. Kanevsky, D.C. C.F.M.P. introduced a new supplement to AgeImmune's product line
earlier this May 2024.
A new addition to the family is Nattokinase supplement in a form of a vegetable capsule
each containing 2,000FU (fibrin unit) representing a unit of potency, which is equal to
100mg. Dr. Kanevsky is recommending a serving size of 2 capsules. However, if you
are in excellent heart health with no family history of blood clots, 1 capsule is enough as
a preventative measure.
Nattokinase is an enzyme derived from Japanese soybean called Natto via fermentation
process with a bacteria called Bacillus subtilis. Natto has been consumed as a
traditional food in Asia for over 2000 years and is believed to be a significant contributor

More on The PennZone
  • Philadelphia's Own Reverend Jamie Knight Returns with "Award-Winning Love
  • Kolbus Introduces the Next Step in Casemaking Efficiency
  • Florida Law Advisers, P.A. Named Best Divorce Firm of 2026 by Expert Law Attorneys
  • Sounds of LA County: 27 Parks.108 Concerts. One County
  • Only One Flight Stands Between Los Angeles Youth Leaders and a Life-Saving Mission in South Africa

to the longevity of the Japanese people. Although natto has been consumed in Asia for
thousands of years, the fibrinolytic and antithrombolytic property of Nattokinasae was
only discovered in 1987. Recent studies demonstrated that high natto intake is
associated with decreased risk of cardiovascular disease.
This was a sufficient reason for Dr. Kanevsky to add Nattokinase to his line of products.
There is some early evidence that nattokinase may thin the blood and help break up
blood clots. This might protect against heart disease and conditions caused by blood
clots such as stroke, heart attack, and others.
Other studies show that nattokinase may help lower blood pressure and reduce
inflammation in the body.
Unlike traditional blood thinning medications, nattokinase is a natural, widely available
and inexpensive supplement with minimal to no side effects which makes is very

More on The PennZone
  • Blueshirt Media Joins the Dazos Partner Program, Expanding HIPAA-Compliant AI Admissions Support for Behavioral Health Organizations
  • Stigma Across Borders: Concerns Grow Over Discrimination Against Shincheonji Members Abroad
  • Roohid Parast, J&J Scientist, Comments on New Psoriasis Biomarker Study
  • World Cup Crowds Are a Stress Test for America's Restrooms
  • Postmortem Pathology Expands Access to Private Autopsy Services in Las Vegas

attractive to Dr. Kanevsky's patients searching for an all-natural approach to their
health.
Having a large database of functional medicine patients Dr Kanevsky easily analyzed
the frequency of complains of a poor heart health, circulation, blood pressure and came
to a conclusion that Nattokinase will become one of the most popular products for
AgeImmune.
As always encapsulated without harmful excipients such as magnesium stearate, silicon
dioxide or titanium dioxide, AgeImmune's Nattokinase is one of the purest professional
grade supplement on the market.
Nattokinase supplement is derived from soy. Dr. Kanevsky warns that if you are allergic
to soy, you shouldn't be taking Nattokinase. It is currently available for purchase at a
discounted price of 21.99 on AgeImmune's website and on Amazon

Contact
AgeImmine
***@netembark.com


Source: Nattokinase Heart Health Supplement

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • AutomationIQ Launches to Bring Enterprise-Grade AI Automation to Local and Mid-Market Businesses
  • Texas Hospitals & Their Patients Describe Two Very Different Healthcare Systems, New Social Knowing
  • DEPIN Studios Sees Surge in Demand After AI Gaming Launch
  • Discard Junk Removal Named #1 Junk Removal Company in Sacramento Out of 189 Businesses Evaluated
  • J&J Exterminating Mourns the Passing of Founder Bobby John Sr
  • Delirious Comedy Club Transforms Into Las Vegas' Newest Live Comedy Studio With Weekly Delirious TV Tapings
  • BitTitan Advances MigrationWiz with New Capabilities, Platform Enhancements, and Product Leadership Update
  • Sara Abbas Receives "Eniochos" Charioteer Award at 2026 Who is Who International Awards
  • Detained at 95: South Korea's Prosecution of a Religious Leader Draws International Alarm
  • CCHR: DOJ Takedown Exposes Over $220 Million Defrauded in Behavioral Mental Health Fraud Schemes
  • Exeter Smiles Encourages Reading Families to Start Teen Braces This Summer
  • ARC Technologies Announces Corporate Asset Sale of buildings, inventory and IP patents
  • Lady Liberty Is Coming Home: Historic WWII A-26 Invader Begins Her Final Journey to the Tulsa Air & Space Museum
  • The Lashe Announces Limited-Time Sale on Professional Premade Fan Lash Extension Trays
  • PropAccount.com Adds Prediction Markets to Its Multi-Asset Prop Firm Platform
  • ToyLookup.com Launches AI-Powered Platform to Help Collectors Identify Vintage and Modern Toys
  • Rising star Hip-Hop and R&B Force Della Drops Highly Anticipated New Single, "Throw It"
  • UK Financial Ltd. Opens Test-Phase Maya 3 Liquidity Pool on Uniswap with DEX Screener Visibility for Market-Smoothing Ahead of CATEX Exchange Launch
  • From DECA Finalist to Translational Scientist: Roohid Parast on Business Training in Biopharma
  • Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers

Popular on PennZone

  • ReviewsAlly Launches Evidence-Based Review Platform for VPNs, Business Software, and Online Services
  • Expanding Access to Mental Health Care in Toronto with Dr. Stephen Shainbart
  • Brilliant Minds to Gather in Fort Worth for National Mensa Event
  • Equipment Leases, Inc. Launches Updated Family Office Equipment Financing Page
  • West Virginia Leaders Announce Support for Election Integrity Network's Model Election Laws Handbook
  • STO Foundation Launching June 29, 2026 to Advance the Global Tokenization Industry
  • Dr. Stephen Shainbart Launches Expanded Mental Health Support for Anxiety and Depression in Toronto
  • Haven Media Solutions Offers Web Design and PPC Services in Atlanta GA
  • Beemok Hospitality Collection And KLH Group Announce Preferred Partnership
  • TREND Network Announces Miami Based Reality Series "Coming Up Miami" Premiering July 1

Similar on PennZone

  • Blueshirt Media Joins the Dazos Partner Program, Expanding HIPAA-Compliant AI Admissions Support for Behavioral Health Organizations
  • World Cup Crowds Are a Stress Test for America's Restrooms
  • Postmortem Pathology Expands Access to Private Autopsy Services in Las Vegas
  • ENTOUCH Named Top 100 Inspiring Workplaces in North America for Third Consecutive Year
  • Texas Hospitals & Their Patients Describe Two Very Different Healthcare Systems, New Social Knowing
  • CCHR: DOJ Takedown Exposes Over $220 Million Defrauded in Behavioral Mental Health Fraud Schemes
  • Exeter Smiles Encourages Reading Families to Start Teen Braces This Summer
  • Why More Phoenix Families Are Turning to Private Autopsy Services for Answers
  • Vierra Communities Adds Operations of Two Skilled Nursing Facilities in the DC Metro Area
  • Dentists launch independent platform to help practices choose the right technology
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us